ARIMIDEX is indicated to the treatment of advanced breast cancer in postmenopausal women with condition progression next tamoxifen therapy. People with ER-adverse illness and clients who didn't respond to earlier tamoxifen therapy rarely responded to ARIMIDEX. The incidences of the next adver